Project Confirm: Accelerated Drug Approvals for CML—Letter-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Project Confirm: Accelerated Drug Approvals for CML—Letter

Published:2024-01-05 Issue:1 Volume:30 Page:235-236
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:

Author:

Beumer Jan H.¹²³^ORCID,Salamone Salvatore J.⁴^ORCID

Affiliation:

1. 1Cancer Therapeutics Program, UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania.

2. 2Division of Hematology-Oncology, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.

3. 3Department of Pharmaceutical Sciences, School of Pharmacy, University of Pittsburgh. Pittsburgh, Pennsylvania.

4. 4Saladax Biomedical Inc., Bethlehem, Pennsylvania.

Funder

National Cancer Institute

Publisher

American Association for Cancer Research (AACR)

Link

https://aacrjournals.org/clincancerres/article-pdf/30/1/235/3394793/235.pdf

Reference5 articles.

1. Project confirm: accelerated drug approvals for chronic myeloid leukemia;Sweet;Clin Cancer Res,2023

2. Who is in charge of assessing therapeutic drug monitoring? The case of imatinib;Buclin;Lancet Oncol,2011

3. All optimal dosing roads lead to therapeutic drug monitoring-why take the slow lane;Beumer;JAMA Oncol,2022

4. Therapeutic drug monitoring in oncology: international association of therapeutic drug monitoring and clinical toxicology consensus guidelines for imatinib therapy;Clarke;Eur J Cancer,2021

5. Response-based dosing for ponatinib: model-based analyses of the dose-ranging OPTIC study;Hanley;Clin Pharmacol Ther,2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP